$16.15
Price
$993M
Market Cap
—
P/E Ratio
-6.3
Forward P/E
$-3.37
EPS (TTM)
—
Dividend Yield
$352M
Cash
$3M
Total Debt
61M
Shares Out
$5.68
$16.74
52-Week Range
Institutional Ownership of CULLINAN THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for CULLINAN THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2022-Q4 | |||||
| SELL | EXIT | — | — | $12.35 | |
| 2022-Q3 | |||||
| SELL | -72.0% | 429.6K | $6M | $13.42 | |
| 2021-Q4 | |||||
| SELL | -16.3% | 1.5M | $23M | $20.96 | |
| 2021-Q1 | |||||
| BUY | NEW | 1.8M | $72M | $39.68 | |
Insider Trading for CULLINAN THERAPEUTICS INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.